RxDoctor Payments Data

Jonathan Furmanek, DPM

Foot & Ankle Surgery · Baltimore, MDNPI 1447710124

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,387 of the $8,942 with a category attached, or 60.2%. It is spread thinly across 25 manufacturers, the largest accounting for just 20.7%. Reporting peaked in 2022 at $3,064 and has fallen 59.8% since, to $1,233 in 2025.

$8,942in general payments, 2019–2025

Across 134 payments — averaging $66.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Arthrex$1K
  • Aroa Biosurgery Incorporated$1K
  • Supreme Orthopedic Systems, LLC$1K
  • Smith+Nephew$658
  • Coastal Medical Technologies LLC$609
  • plus $2K from 19 others

What the payments were for

  • Travel & lodging$3,55540%
  • Food & beverage$5,38760%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,942 in reported general payments places this provider in the 75th percentile of 182 foot & ankle surgery providers in Maryland.

See all foot & ankle surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$174,204
Medicare patients
204
Services billed
1,291

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox22$803
Terbinafine Hcl11$202
Doxycycline Hyclate17$193
Gabapentin14$114

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →